Fig. 1.

Nature of HyQvia ramp-up (a) and maintenance (b) variations by discontinuation^a status in each phase. ^a Discontinuations for clinical reasons. ^b Two non-discontinuation patients in this category used a faster infusion rate than recommended; six non-discontinuation patients in this category used a slower infusion rate than recommended. ^c All four patients in this category used a slower infusion rate than recommended. ^d One non-discontinuation patient in this category also used a slower infusion rate. ^e One patient in this category also infused at a slower rate